PTC Therapeutics (PTCT) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, PTC Therapeutics (PTCT) reported revenue of $213.17 million, down 30.6% over the same period last year. EPS came in at -$ 0.24, compared to - $0.24 in the year-ago quarter.The reported revenue represents a surprise of -3.96% over the Zacks Consensus Estimate of$ 221.96 million. With the consensus EPS estimate being -$0.96, the EPS surprise was +75.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...